
Independence Blue Cross (IBX) has selected Jefferson Health, Penn Medicine, and Temple Health as 2026 Clinical Care Innovation Grant recipients. The grants help hospitals and doctors create new care approaches that improve health outcomes, remove barriers, and make health care more affordable.
“Our 2026 Clinical Care Innovation Grants keep innovation close to the point of care, where it matters most. We’re proud to partner with leading health systems to advance programs that improve care for serious conditions. This year, the programs focus on earlier detection and management of dementia, better support after a breast cancer diagnosis, and helping people with Type 2 diabetes manage their health better. Together, our goal is simple: to get patients to the right care faster, improve their experience and outcomes, and make care more affordable.” Dr. Rodrigo Cerdá, Senior Vice President of Health Services and Chief Medical Officer at Independence Blue Cross.
The three projects selected for grants include:
- “Improving Dementia Care in Primary Practice,” led by Dr. Barry Rovner, Professor, Department of Psychiatry, Neurology and Ophthalmology at Jefferson Health. This project focuses on a program that helps doctors in primary care settings more easily find and manage Alzheimer’s Disease in older adults, while enhancing the experience patients have. It gives patients education and personal support from a Community Health Worker, who helps them make decisions about their care. It also helps doctors by providing test results and smart tools for ordering the right tests.
- “CURE-BC: Coordinating Upstream Rapid Entry for Breast Cancer,” led by Dr. Oluwadamilola “Lola” Fayanju, Chief, Division of Breast Surgery at Penn Medicine. This project focuses on restructuring the critical period immediately following a breast cancer diagnosis so that within 48 hours, patients will have a virtual visit with a nurse, their information will be organized, and appointments with specialists will be set up.
- “Temple Aide – Leveraging a Novel, Conversational AI Tool to Support Type 2 Diabetes Management in the Primary Care Setting,” led by Dr. Janet Lee, Assistant Dean for Clinical Research; Dr. Laura Igarabuza, Assistant Professor, Clinical Family and Community Medicine and Center for Urban Bioethics; and Jillian Jatres, Research Director at Temple Health. This project aims to help people with Type 2 Diabetes manage their condition better by using a new AI chatbot tool that supports patients in following their medication plans and keeping their blood sugar under control.
To date, Independence has awarded 24 Clinical Care Innovation Grants valued at more than $4.8M to health systems and large specialty groups. For more information about the grants, visit ibx.com/ccigrant.
Media contact:
Diana Quattrone
215-815-7828 (cell)
Diana.Quattrone@ibx.com


